U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H8N2O4
Molecular Weight 184.1494
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3,4,5-TRIHYDROXYBENZAMIDOXIME

SMILES

ONC(=N)C1=CC(O)=C(O)C(O)=C1

InChI

InChIKey=MSLJYSGFUMYUDX-UHFFFAOYSA-N
InChI=1S/C7H8N2O4/c8-7(9-13)3-1-4(10)6(12)5(11)2-3/h1-2,10-13H,(H2,8,9)

HIDE SMILES / InChI

Molecular Formula C7H8N2O4
Molecular Weight 184.1494
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.
2000 Aug
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:20:33 GMT 2023
Edited
by admin
on Fri Dec 15 18:20:33 GMT 2023
Record UNII
WRR9SR69TE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3,4,5-TRIHYDROXYBENZAMIDOXIME
Systematic Name English
N,3,4,5-TETRAHYDROXYBENZIMIDAMIDE
Systematic Name English
VF-233
Code English
BENZENECARBOXIMIDAMIDE, N,3,4,5-TETRAHYDROXY-
Systematic Name English
N,3,4,5-TETRAHYDROXYBENZENECARBOXIMIDAMIDE
Systematic Name English
TRIMIDOX
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID40914733
Created by admin on Fri Dec 15 18:20:33 GMT 2023 , Edited by admin on Fri Dec 15 18:20:33 GMT 2023
PRIMARY
FDA UNII
WRR9SR69TE
Created by admin on Fri Dec 15 18:20:33 GMT 2023 , Edited by admin on Fri Dec 15 18:20:33 GMT 2023
PRIMARY
CAS
95933-74-7
Created by admin on Fri Dec 15 18:20:33 GMT 2023 , Edited by admin on Fri Dec 15 18:20:33 GMT 2023
PRIMARY
PUBCHEM
5464467
Created by admin on Fri Dec 15 18:20:33 GMT 2023 , Edited by admin on Fri Dec 15 18:20:33 GMT 2023
PRIMARY